Daniel J O'Connell

Bio

Dan is one of the founders and serves as managing partner of NeuroVentures, a specialty venture firm, established in 2001 to invest in emerging biopharmaceutical and medical technology companies developing better treatments for Central Nervous System diseases. Dan represents NeuroVentures on the boards of Setagon Inc. and Acumen Pharmaceuticals, Inc. In addition, he serves as a board observer at BrainCells Inc., Concentric Medical Inc., and previously Cyberkinetics Neurotechnology Systems Inc. Dan’s experience with neuro-related technology companies includes co-founding MedSpecialists, Inc., a venture-backed clinical applications provider acquired by ProVation Medical Inc., and Surgical Solutions, LLC, a company which developed and marketed neurosurgical products licensed from leading research institutions. Prior to attending business school, Dan worked in investment banking at Advest, Inc. Dan is a member of the Business Advisory Boards of the Epilepsy Therapy Development Project and the Alzheimer's Drug Discovery Foundation. He serves on the Board of the Neurotechnology Industry Organization. He holds a B.A. from Brown University and M.B.A. from the University of Virginia.